BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Editorial

  Eli Lilly and the LA Dodgers: A tale of 2 dynasties

  Watching the baseball playoffs this week, I was struck by the parallels between the Los Angeles Dodgers and Eli Lilly. Both franchises spend a lot of money and always appear to come out on top.

  October 8, 2026

   · 

  3 min read

   · 

  Heather McKenzie
• Press Releases

  CollectiveMinds LLC Supports the Appointment of J.D. Mowery to Argonaut Manufacturing Services Board of Directors

  October 8, 2026

   · 

  3 min read
• Press Releases

  bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

  October 8, 2026

   · 

  4 min read
• Press Releases

  TMC Group Reports Progress on Capacity Expansion Ahead of EANM 2026

  October 8, 2026

   · 

  2 min read
• Press Releases

  LEO Pharma to Present 21 Posters Across Chronic Hand Eczema, Generalized Pustular Psoriasis, Atopic Dermatitis and Pyoderma Gangrenosum at the 2026 Fall Clinical Dermatology Conference

  October 8, 2026

   · 

  19 min read
• Press Releases

  AviadoBio Presents New Safety and Biomarker Data from the Phase 1/2 ASPIRE-FTD Trial at the International Conference on Frontotemporal Dementias

  October 8, 2026

   · 

  5 min read
• Press Releases

  WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

  October 8, 2026

   · 

  4 min read
• 

  Manufacturing

  Merck barred from making subcutaneous Keytruda in 8 European countries

  With the patent court siding with Halozyme, Merck faces restrictions on a product that won approval in Europe last year.

  October 8, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor
• Press Releases

  Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

  October 8, 2026

   · 

  5 min read
• Press Releases

  ALCMI and Sophos IRB Form Strategic Partnership to Advance Lung Cancer Clinical Research

  October 8, 2026

   · 

  3 min read